EU Accelerated Assessment Tracker
Executive Summary
Alnylam's European marketing authorization application for givosiran will be fast-tracked when the company files for approval. Only three of the nine accelerated assessment requests that the European Medicines Agency has processed this year have been successful. See our latest updates in the tracker below.